Mayinglong Pharmaceutical Group Co., LTD.

Shanghai Stock Exchange 600993.SS

Mayinglong Pharmaceutical Group Co., LTD. Free Cash Flow Per Share for the year ending December 31, 2023: USD 0.12

Mayinglong Pharmaceutical Group Co., LTD. Free Cash Flow Per Share is USD 0.12 for the year ending December 31, 2023, a 29.78% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

Mayinglong Pharmaceutical Group Co., LTD. Free Cash Flow Per Share for the year ending December 31, 2022 was USD 0.09, a -53.82% change year over year.
Mayinglong Pharmaceutical Group Co., LTD. Free Cash Flow Per Share for the year ending December 31, 2021 was USD 0.19, a 130.07% change year over year.
Mayinglong Pharmaceutical Group Co., LTD. Free Cash Flow Per Share for the year ending December 31, 2020 was USD 0.08, a -43.07% change year over year.
Mayinglong Pharmaceutical Group Co., LTD. Free Cash Flow Per Share for the year ending December 31, 2019 was USD 0.15, a 54.76% change year over year.

Key data

Date	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)

Shanghai Stock Exchange: 600993.SS

Mayinglong Pharmaceutical Group Co., LTD.

CEO	Mr. Youzhang Xia
IPO Date	May 17, 2004
Location	China
Headquarters	100 Zhoujia Wan
Employees	2,882
Sector	Health Care
Industries Pharmaceuticals Cosmetics Drugstores & Retail Pharmacies

Description

Mayinglong Pharmaceutical Group Co., LTD. engages in the manufacture, wholesale, and retail of pharmaceutical products primarily in China. It offers hemorrhoid, gynecological, cough, skin, functional food, and Chinese medicine drink tablet products, as well as medical devices. The company also sells its products online. It also operates hospitals. Mayinglong Pharmaceutical Group Co., LTD. was founded in 1582 and is based in Wuhan, China.

Key trends

Past 5 years